CNBC · Finance · 2026-08-20
This fertility benefit business is set to boom. Buy the stock now, Wells Fargo says
Progyny is set to benefit from several structural tailwinds, including catalysts that should help it court more clients, according to Wells Fargo. This fertility benefit business is set to boom. Buy the stock now, Wells Fargo says
Read original on CNBC Get the app
Licensed summary · LicensedSummary
Related briefs
- California AG tells CNBC that settling Paramount-WBD lawsuit would require 'robust structural remedies'
- Saatvik Green Energy arm bags ₹190 crore solar PV module order
- AI data center outrage is showing up everywhere from ads to elections
- Wall Street stocks edge lower as bond yields rebound
- This Kansas City regional bank is playing with the big boys. JPMorgan sees big gains ahead